Integrated Biosciences
Integrated Biosciences is a biotechnology company focused on accelerating small molecule drug discovery. They leverage a proprietary synthetic biology toolkit, including advanced optogenetic tools for precise control of biological pathways. Their platform integrates chemistry and computation, powered by extensive datasets and AI models, to tackle complex and difficult-to-drug targets. This approach aims to generate novel chemical matter and provide solutions for challenging biological systems.
Integrated Biosciences
Integrated Biosciences is a biotechnology company focused on accelerating small molecule drug discovery. They leverage a proprietary synthetic biology toolkit, including advanced optogenetic tools for precise control of biological pathways. Their platform integrates chemistry and computation, powered by extensive datasets and AI models, to tackle complex and difficult-to-drug targets. This approach aims to generate novel chemical matter and provide solutions for challenging biological systems.
TL;DR
Founded: September 2022
Headquarters: Redwood City, California
Focus: Small-molecule drug discovery using optogenetics, synthetic biology, chemistry, and AI
Latest raise: $17.2M seed (Oct 3, 2024)
Team size: ~16 employees
Company Overview
Problem Domain
Discovery of small-molecule therapeutics for age-related and hard-to-drug biological targets.
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
$17.2M
13-investor syndicate including Root Ventures, Civilization Ventures, Illumina Ventures Labs, Lifespan Vision Ventures, Vijay Pandurangan, and others.
Investor Signal
“Led by established life-sciences investor Sutter Hill Ventures with participation from multiple specialized VC firms and angel investors”